NEUROONE MEDICAL TECHNOLOGIE (NMTC) Stock Analyst Earnings Estimates
NASDAQ:NMTC - Nasdaq - US64130M2098 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.12M 783.33% | 3.448M 62.66% | 3.453M 0.13% | 8.884M 157.28% | 12.597M 41.79% | 17.707M 40.57% | 23.491M 32.67% | |
| EBITDA YoY % growth | -9.91M 2.27% | -11.756M -18.63% | -11.64M 0.98% | -13.566M -16.54% | N/A | N/A | N/A | |
| EBIT YoY % growth | -10.03M 1.86% | -11.955M -19.20% | -11.887M 0.57% | -5.773M 51.43% | -8.486M -47.00% | -6.712M 20.91% | -3.703M 44.83% | |
| Operating Margin | -473.11% | -346.69% | -344.26% | -64.98% | -67.37% | -37.90% | -15.76% | |
| EPS YoY % growth | -0.63 39.74% | -0.65 -3.17% | N/A 34.09% | -0.13 69.05% | -0.15 -15.38% | -0.11 26.67% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.05 50.00% | -0.04 62.91% | -0.04 -168.00% | -0.05 27.14% |
| Revenue Q2Q % growth | 1.856M 124.75% | 2.275M 742.59% | 2.407M -26.39% | 2.805M 101.80% |
| EBITDA Q2Q % growth | -3.264M -25.06% | -3.06M -19.07% | N/A | N/A |
| EBIT Q2Q % growth | -2.519M 9.70% | -2.254M 19.97% | -2.315M -235.31% | -2.428M 9.42% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.07 36.36% | -0.09 | 0.02 | 23.75% |
| Q1 2025 Q2Q % growth | 0.06 142.86% | -0.10 | 0.16 | 158.82% |
| Q4 2024 Q2Q % growth | -0.11 15.38% | -0.08 | -0.03 | -34.80% |
| Q3 2024 Q2Q % growth | 49.00% | -0.10 | % | |
| Q2 2024 Q2Q % growth | -0.11 47.62% | -0.10 | -0.01 | -7.84% |
| Q1 2024 Q2Q % growth | -0.14 -27.27% | -0.14 | 0.00 | 1.96% |
| Q4 2023 Q2Q % growth | -0.13 -44.44% | -0.18 | 0.05 | 27.17% |
| Q3 2023 Q2Q % growth | -0.20 -17.65% | -0.21 | 0.01 | 4.35% |
| Q2 2023 Q2Q % growth | -0.21 -10.53% | -0.21 | 0.00 | -0.43% |
| Q1 2023 Q2Q % growth | -0.11 38.89% | -0.11 | 0.00 | 1.96% |
| Q4 2022 Q2Q % growth | -0.09 59.09% | -0.11 | 0.02 | 19.79% |
| Q3 2022 Q2Q % growth | -0.17 32.00% | -0.23 | 0.06 | 25.93% |
| Q2 2022 Q2Q % growth | -0.19 | -0.20 | 0.01 | 6.86% |
| Q1 2022 Q2Q % growth | -0.18 | -0.19 | 0.01 | 4.61% |
| Q4 2021 Q2Q % growth | -0.22 | -0.22 | 0.00 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.39M 0.72% | 2.448M | -1.058M | -43.22% |
| Q1 2025 Q2Q % growth | 3.27M 234.48% | 2.142M | 1.128M | 52.66% |
| Q4 2024 Q2Q % growth | 270K -65.50% | 2.346M | -2.076M | -88.49% |
| Q3 2024 Q2Q % growth | 825.8K 31.08% | 2.04M | -1.214M | -59.52% |
| Q2 2024 Q2Q % growth | 1.38M 196.14% | 1.734M | -354K | -20.42% |
| Q1 2024 Q2Q % growth | 977.65K -37.73% | 869.04K | 108.61K | 12.50% |
| Q4 2023 Q2Q % growth | 782.52K -61.07% | 816K | -33.48K | -4.10% |
| Q3 2023 Q2Q % growth | 630K 2,000.00% | 357K | 273K | 76.47% |
| Q2 2023 Q2Q % growth | 466K 1,065.00% | 255K | 211K | 82.75% |
| Q1 2023 Q2Q % growth | 1.57M 3,825.00% | 1.938M | -368K | -18.99% |
| Q4 2022 Q2Q % growth | 2.01M 3,920.00% | 3.672M | -1.662M | -45.26% |
| Q3 2022 Q2Q % growth | 30K -50.00% | 30K | % | |
| Q2 2022 Q2Q % growth | 40K | 40K | % | |
| Q1 2022 Q2Q % growth | 40K -55.56% | 40K | % | |
| Q4 2021 Q2Q % growth | 50K -97.41% | 102K | -52K | -50.98% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 28.57% | 7.14% | 53.57% |
| Revenue | 0% | -32.61% | 6.74% | -34.51% |